World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
29034
World Ranking
11376
National Ranking
335

Hisashi Yamanaka publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Hisashi Yamanaka sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 737 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Hisashi Yamanaka D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Hisashi Yamanaka sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Hisashi Yamanaka is affiliated with the International University of Health and Welfare in Japan. Their research primarily focuses on medicine, with a strong emphasis on rheumatology. The subfields they have contributed to include rheumatology, genetics, pathology and forensic medicine, hematology, and nephrology.

Their recent publications address various aspects of rheumatology and related conditions. Notable papers include:

  • Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication (2022, Modern Rheumatology)
  • Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases (2022, Rheumatology and Therapy)
  • Real-world treatment of gout and asymptomatic hyperuricemia: A cross-sectional study of Japanese health insurance claims data (2020, Modern Rheumatology)
  • Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study (2022, Scientific Reports)
  • Serum uric acid control for prevention of gout flare in patients with asymptomatic hyperuricaemia: a retrospective cohort study of health insurance claims and medical check-up data in Japan (2021, Annals of the Rheumatic Diseases)

Yamanaka's work covers a range of main topics including rheumatoid arthritis research and therapies, chronic lymphocytic leukemia research, lymphoma diagnosis and treatment, systemic lupus erythematosus research, autoimmune and inflammatory disorders research, gout, hyperuricemia and uric acid, as well as monoclonal and polyclonal antibodies research.

Frequent coauthors in their research include:

  • Masayoshi Harigai
  • Eisuke Inoue
  • Eiichi Tanaka
  • Katsunori Ikari
  • Naohiro Sugitani

Their studies have been published primarily in several key venues specialized in rheumatology and related medical fields. These publication venues include:

  • Modern Rheumatology
  • Annals of the Rheumatic Diseases
  • Rheumatology and Therapy
  • Clinical Rheumatology
  • BMC Pediatrics

Best Publications

  • Genetics of rheumatoid arthritis contributes to biology and drug discovery

    Yukinori Okada;Yukinori Okada;Di Wu;Di Wu;Di Wu;Gosia Trynka;Gosia Trynka;Towfique Raj;Towfique Raj

  • A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: Evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy

    Akira Shoji;Hisashi Yamanaka;Naoyuki Kamatani

  • Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values

    Eisuke Inoue;Hisashi Yamanaka;Masako Hara;Taisuke Tomatsu

  • Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis

    Tsutomu Takeuchi;Y. Tatsuki;Y. Nogami;N. Ishiguro

  • Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population

    Yukinori Okada;Chikashi Terao;Katsunori Ikari;Yuta Kochi

  • Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses.

    Wako Urano;Atsuo Taniguchi;Hisashi Yamanaka;Eiichi Tanaka

  • Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis

    Kevin L. Winthrop;Hisashi Yamanaka;Hernan Valdez;Eric Mortensen

  • Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis

    Takahisa Gono;Shinji Sato;Yasushi Kawaguchi;Masataka Kuwana

  • Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis

    Takahisa Gono;Yasushi Kawaguchi;Takashi Satoh;Masataka Kuwana

  • A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility.

    Yuta Kochi;Yukinori Okada;Akari Suzuki;Katsunori Ikari

  • Japanese Guideline for the Management of Hyperuricemia and Gout: Second Edition

    Hisashi Yamanaka

  • DOES HYPERURICEMIA AEFFECT MORTALITY? A Prospective Cohort Study of Japanese Male Workers

    Masako Tomita;Shouichi Mizuno;Hisashi Yamanaka;Yutaka Hosoda

  • Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study

    Tuulikki Sokka;Hannu Kautiainen;Theodore Pincus;Suzanne M.M. Verstappen

  • Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial

    Kenjiro Kimura;Tatsuo Hosoya;Shunya Uchida;Masaaki Inaba

  • Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis.

    Hisashi Yamanaka;Yuko Matsuda;Michi Tanaka;Wako Sendo

  • The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis

    Wako Urano;Hisashi Yamanaka;Hiroshi Tsutani;Hiroshi Nakajima

  • Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis

    Yuko Matsuda;Gurkirpal Singh;Hisashi Yamanaka;Eiichi Tanaka

  • Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients

    Takao Koike;Masayoshi Harigai;Naoki Ishiguro;Shigeko Inokuma

  • Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease

    Takahisa Gono;Hirotaka Kaneko;Yasushi Kawaguchi;Masanori Hanaoka

  • Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients

    Takao Koike;Masayoshi Harigai;Shigeko Inokuma;Naoki Ishiguro

Frequent Co-Authors

Naoyuki Kamatani
Naoyuki Kamatani StaGen (Japan)
Yoshiya Tanaka
Yoshiya Tanaka University of Occupational and Environmental Health Japan
Tsutomu Takeuchi
Tsutomu Takeuchi Keio University
Masako Hara
Masako Hara National Defense Medical College
Yasushi Kawaguchi
Yasushi Kawaguchi University of Tokyo
Takao Koike
Takao Koike Hokkaido University
Naoki Ishiguro
Naoki Ishiguro Nagoya University
Tsuneyo Mimori
Tsuneyo Mimori Kyoto University
Nobuyuki Miyasaka
Nobuyuki Miyasaka Tokyo Medical and Dental University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine but want to explore alternative or complementary paths, there are a number of flexible online degree programs to consider. These programs can provide options for advancing in healthcare fields without committing to a full medical degree.

Nursing is an in-demand pathway, and many find the online msn pmhnp programs particularly appealing. These programs prepare graduates to become Psychiatric Mental Health Nurse Practitioners, a specialized and rapidly growing area of healthcare.

For those interested in the management and organizational side of medicine, a health care administration online degree offers essential skills for leadership roles. You can also consider the most affordable online mha programs to pursue your master's in healthcare administration at lower costs.

Aspiring to reach the highest levels of nursing? The most affordable online dnp programs allow nurses to achieve doctoral-level credentials online, unlocking advanced practice and leadership opportunities.

These flexible online options can make it easier to advance your healthcare career, whether you aim for clinical, administrative, or specialized roles.

Best Scientists Citing Hisashi Yamanaka

Trending Scientists

Recently Published Articles